Manulife (Manufacturers Life Insurance)
OCDX

Manulife (Manufacturers Life Insurance)’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-226,806
Closed -$4.23M – 3252
2022
Q1 		$4.23M Buy
226,806
+167,724
+284% +$3.02M ﹤0.01% 1268
2021
Q4 		$1.26K Buy
59,082
+4,329
+8% +$85.3K ﹤0.01% 1689
2021
Q3 		$1.01M Buy
54,753
+7,107
+15% +$143K ﹤0.01% 1827
2021
Q2 		$1.02M Sell
47,646
-93
-0.2% -$1.89K ﹤0.01% 1986
2021
Q1 		$921K Buy
+47,739
New +$841K ﹤0.01% 1942

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s OCDX Position: Q2 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 226,806 shares — an estimated $4.23M sold.

Manulife (Manufacturers Life Insurance) first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $4.23M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 226,806 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $4.23M.
  • Manulife (Manufacturers Life Insurance) first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
  • Manulife (Manufacturers Life Insurance)'s Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $4.23M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.